Nalaganje...
Geniposide Protects against Obesity-Related Cardiac Injury through AMPKα- and Sirt1-Dependent Mechanisms
Our previous study found that geniposide, an agonist of glucagon-like peptide-1 receptor (GLP-1R), protected against cardiac hypertrophy via the activation of AMP-activated protein kinase α (AMPKα). However, the effects of geniposide on obesity-related cardiac injury remain unknown. Here, we examine...
Shranjeno v:
| izdano v: | Oxid Med Cell Longev |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Hindawi
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6247476/ https://ncbi.nlm.nih.gov/pubmed/30533173 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/6053727 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|